| 000 | 01901 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250517072134.0 | ||
| 264 | 0 | _c20161213 | |
| 008 | 201612s 0 0 eng d | ||
| 022 | _a1791-2423 | ||
| 024 | 7 |
_a10.3892/ijo.2015.3311 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNeil, Jayson | |
| 245 | 0 | 0 |
_aATP-site binding inhibitor effectively targets mTORC1 and mTORC2 complexes in glioblastoma. _h[electronic resource] |
| 260 |
_bInternational journal of oncology _cMar 2016 |
||
| 300 |
_a1045-52 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdenosine Triphosphate _xchemistry |
| 650 | 0 | 4 | _aBinding, Competitive |
| 650 | 0 | 4 |
_aBrain Neoplasms _xmetabolism |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aCell Movement |
| 650 | 0 | 4 | _aCell Proliferation |
| 650 | 0 | 4 | _aCell Survival |
| 650 | 0 | 4 | _aChemotaxis |
| 650 | 0 | 4 |
_aExtracellular Signal-Regulated MAP Kinases _xmetabolism |
| 650 | 0 | 4 |
_aGlioblastoma _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIndoles _xchemistry |
| 650 | 0 | 4 |
_aInsulin _xchemistry |
| 650 | 0 | 4 | _aMechanistic Target of Rapamycin Complex 1 |
| 650 | 0 | 4 | _aMechanistic Target of Rapamycin Complex 2 |
| 650 | 0 | 4 |
_aMultiprotein Complexes _xmetabolism |
| 650 | 0 | 4 | _aPhenotype |
| 650 | 0 | 4 |
_aPhosphorylation _xdrug effects |
| 650 | 0 | 4 | _aProtein Binding |
| 650 | 0 | 4 |
_aPurines _xchemistry |
| 650 | 0 | 4 | _aS Phase |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 |
_aSirolimus _xchemistry |
| 650 | 0 | 4 |
_aTOR Serine-Threonine Kinases _xmetabolism |
| 700 | 1 | _aShannon, Craig | |
| 700 | 1 | _aMohan, Avinash | |
| 700 | 1 | _aLaurent, Dimitri | |
| 700 | 1 | _aMurali, Raj | |
| 700 | 1 | _aJhanwar-Uniyal, Meena | |
| 773 | 0 |
_tInternational journal of oncology _gvol. 48 _gno. 3 _gp. 1045-52 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3892/ijo.2015.3311 _zAvailable from publisher's website |
| 999 |
_c25589054 _d25589054 |
||